Literature DB >> 11927276

Caretaker tumour suppressor genes that defend genome integrity.

Nicola C Levitt1, Ian D Hickson.   

Abstract

Cancers arise as a result of genetic changes that impact upon cell proliferation through promoting cell division and/or inhibiting cell death. Tumour suppressor (TS) genes are the targets for many of these genetic changes. In general, both alleles of TS genes must be disrupted to observe a phenotypic effect. Broadly speaking, there are two types of TS gene: 'gatekeepers' and 'caretakers'. In contrast to gatekeepers, caretaker genes do not directly regulate proliferation, but act to prevent genomic instability. Thus, mutation of caretaker genes leads to accelerated conversion of a normal cell to a neoplastic cell. Many caretaker genes are required for the maintenance of genome integrity. This review focuses on those caretaker genes that play a role, directly or indirectly, in the repair of DNA strand breaks by the homologous recombination pathway, and that are associated with cancer-prone clinical syndromes, in particular ataxia telangiectasia, hereditary breast cancer, Bloom's syndrome and Werner's syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927276     DOI: 10.1016/s1471-4914(02)02298-0

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  31 in total

1.  Effect of Recql5 deficiency on the intestinal tumor susceptibility of Apc(min) mice.

Authors:  Yiduo Hu; Xincheng Lu; Guangbin Luo
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

2.  Aspergillus nidulans uvsBATR and scaANBS1 genes show genetic interactions during recovery from replication stress and DNA damage.

Authors:  Marcia Regina von Zeska Kress Fagundes; Camile P Semighini; Iran Malavazi; Marcela Savoldi; Joel Fernandes de Lima; Maria Helena de Souza Goldman; Steven D Harris; Gustavo Henrique Goldman
Journal:  Eukaryot Cell       Date:  2005-07

3.  DNA content analysis of colorectal cancer defines a distinct 'microsatellite and chromosome stable' group but does not predict response to radiotherapy.

Authors:  Wakkas Fadhil; Karin Kindle; Darryl Jackson; Abed Zaitoun; Nina Lane; Adrian Robins; Mohammad Ilyas
Journal:  Int J Exp Pathol       Date:  2014-02       Impact factor: 1.925

4.  TUSC4 functions as a tumor suppressor by regulating BRCA1 stability.

Authors:  Yang Peng; Hui Dai; Edward Wang; Curtis Chun-Jen Lin; Wei Mo; Guang Peng; Shiaw-Yih Lin
Journal:  Cancer Res       Date:  2014-12-05       Impact factor: 12.701

5.  Bloom syndrome radials are predominantly non-homologous and are suppressed by phosphorylated BLM.

Authors:  Nichole Owen; James Hejna; Scott Rennie; Asia Mitchell; Amy Hanlon Newell; Navid Ziaie; Robb E Moses; Susan B Olson
Journal:  Cytogenet Genome Res       Date:  2015-02-28       Impact factor: 1.636

6.  Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3.

Authors:  Anna M G Pasmooij; Hendri H Pas; Maria C Bolling; Marcel F Jonkman
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

7.  DNA double strand break repair and its association with inherited predispositions to breast cancer.

Authors:  Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2004-02-15       Impact factor: 2.857

8.  An embryo-specific expressing TGF-β family protein, growth-differentiation factor 3 (GDF3), augments progression of B16 melanoma.

Authors:  Nobuyuki Ehira; Hiroyuki Oshiumi; Misako Matsumoto; Takeshi Kondo; Masahiro Asaka; Tsukasa Seya
Journal:  J Exp Clin Cancer Res       Date:  2010-10-15

Review 9.  Genetic unraveling of colorectal cancer.

Authors:  Sabha Rasool; Vamiq Rasool; Tahira Naqvi; Bashir A Ganai; Bhahwal Ali Shah
Journal:  Tumour Biol       Date:  2014-02-27

10.  Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8.

Authors:  Travis J Taylor; David M Knipe
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.